Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,957 | 22,244 | 37,125 | 41,100 | 42,044 |
| Marketable Securities | N/A | 36,121 | N/A | N/A | N/A |
| TOTAL | $80,589 | $61,346 | $38,327 | $41,511 | $42,520 |
| Non-Current Assets | |||||
| PPE Net | 129 | 77 | 109 | N/A | N/A |
| Other Non-Current Assets | 2,061 | 138 | 544 | 486 | 786 |
| TOTAL | $2,190 | $215 | $653 | $486 | $786 |
| Total Assets | $82,779 | $61,561 | $38,980 | $41,997 | $43,306 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,989 | 4,879 | 1,424 | 1,153 | 946 |
| Accrued Expenses | 10,762 | 4,202 | 2,242 | 2,026 | 812 |
| TOTAL | $20,751 | $9,081 | $3,666 | $3,179 | $1,758 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,037 | 0 | 0 | 0 | 0 |
| TOTAL | $1,037 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $21,788 | $9,081 | $3,666 | $3,179 | $1,758 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,886 | 6,582 | 1,456 | 840 | 590 |
| Common Shares | 13 | 6 | 1 | 21 | 15 |
| Retained earnings | -223,373 | -153,998 | -118,520 | -87,044 | -73,165 |
| Other shareholders' equity | 3 | 11 | 4 | 0 | 0 |
| TOTAL | $60,991 | $52,480 | $35,314 | $38,818 | $41,548 |
| Total Liabilities And Equity | $82,779 | $61,561 | $38,980 | $41,997 | $43,306 |